Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.44 |
| ▸ | HTT | P42858 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SGMS1 | Q86VZ5 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29454419 | 0.95 | NPC1 (0.45) | MEN1KMT2ANPC1LMNAALDH1A1 | |
| SCHEMBL15342341 | 0.92 | LMNA (0.43) | MEN1KMT2ANPC1LMNAHTT | |
| SCHEMBL14007040 | 0.91 | KMT2A (0.51) | MEN1KMT2ANPC1LMNAHTT | |
| SCHEMBL31749265 | 0.90 | KMT2A (0.54) | MEN1KMT2ANPC1LMNAHTT | |
| SCHEMBL27214060 | 0.90 | KMT2A (0.54) | MEN1KMT2ANPC1LMNAHTT | |
| SCHEMBL13379273 | 0.90 | KMT2A (0.42) | MEN1KMT2ANPC1ADAMTS5RAB9A | |
| SCHEMBL25647249 | 0.89 | ALDH1A1 (0.44) | MEN1KMT2ANPC1LMNAHTT | |
| SCHEMBL17190820 | 0.89 | KMT2A (0.45) | MEN1KMT2AALDH1A1GAAALOX12 | |
| SCHEMBL12568257 | 0.89 | RAB9A (0.43) | MEN1KMT2ANPC1LMNAHTT | |
| SCHEMBL20586242 | 0.89 | KMT2A (0.48) | MEN1KMT2ANPC1LMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170088582-A1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | RQX PHARMACEUTICALS, INC. (US) | 2017-03-30 | — | — | US | disclosed |
| US-9394341-B2 | Eptifibatide preparation method | CHENGDU SHENGNUO BIOTEC CO., LTD. (CN) | 2016-07-19 | — | — | US | disclosed |
| US-20150299261-A1 | EPTIFIBATIDE PREPARATION METHOD | CHENGDU SHENGNUO BIO TEC CO., LTD. (CN) | 2015-10-22 | — | — | US | disclosed |
| US-8846411-B2 | Derivatives, reagents, and immunoassay for detecting levetiracetam | MICROGENICS CORPORATION (US) | 2014-09-30 | — | — | US | disclosed |
| US-20100317024-A1 | DERIVATIVES, REAGENTS, AND IMMUNOASSAY FOR DETECTING LEVETIRACETAM | MICROGENICS CORPORATION | 2010-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150299261-A1 | EPTIFIBATIDE PREPARATION METHOD | RXFP1, OGFR, RXFP3 | MEN1 4111/4885KMT2A 3326/4885NPC1 4560/4885 |
| US-20100317024-A1 | DERIVATIVES, REAGENTS, AND IMMUNOASSAY FOR DETECTING LEVETIRACETAM | EPM2A, IGLV6-57, LAMTOR3 | MEN1 3801/4885KMT2A 1289/4885NPC1 4577/4885 |
| US-20170088582-A1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | MRPL21, PEPD, CTSC | MEN1 2531/4885KMT2A 3283/4885NPC1 1905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.